July
17
2023
**Resumption of Testing with New Method**
in-house testing of Anti-CCP will resume, but this testing will be performed on the Roche Cobas e801 platform.
While the clinical performance of the assay remains unchanged, the reported values and cut-off values are different from our previous assay.
**Resumption of Testing with New Method**
in-house testing of Anti-CCP will resume, but this testing will be performed on the Roche Cobas e801 platform.
While the clinical performance of the assay remains unchanged, the reported values and cut-off values are different from our previous assay.
